Loading company…
Ozette develops AI software for analyzing cytometry and immune data.
Ozette provides a cloud-based platform that analyzes spectral and conventional cytometry data for biomedical research. Its users include pharmaceutical companies and academic institutions in North America and Europe. In July 2022, the Seattle-based company raised USD 26 mn in Series A funding led by Madrona Venture Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in